Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Interaction between the liver transcriptome and gut microbiota in mice during Toxoplasma gondii infection as identified by integrated transcriptomic and microbiome analysis.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 100966981 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2180 (Electronic) Linking ISSN: 14712180 NLM ISO Abbreviation: BMC Microbiol Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central, [2001-
    • Subject Terms:
    • Abstract:
      Competing Interests: Declarations. Ethics approval and consent to participate: The present study was approved by the Animal Ethics Committee of Qingdao Agricultural University. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
      Background: Toxoplasma gondii is a single-cell parasite capable of infecting both humans and a variety of animal species. Although T. gondii infection is known to adversely affect the liver and gut microbiota, the precise interplay between the gut microbiome and the liver transcriptome in infected mice remains largely unknown. In this study, we artificially induced acute and chronic stages of T. gondii infection in BALB/c mice via the oral of low doses (n = 10) of PRU (Type II) bradyzoites. Then, we performed fecal 16S rRNA gene amplicon sequencing and RNA transcriptome sequencing to investigate the composition of the gut microbiota and the expression profiles of long non-coding RNAs (lncRNAs), circular RNAs (circRNAs), microRNAs (miRNAs), and messenger RNAs (mRNAs) in the livers of mice infected with T. gondii at different stages of infection.
      Results: Analysis revealed dynamic alterations in the gut microbiota of mice following infection with T. gondii over the course of the infection cycle. Notably, we observed a significant increase in the abundance of Enterobacteriaceae during the acute stage of infection, while the abundance of Lactobacteriaceae was elevated during the chronic stage. Liver transcriptome analysis identified numerous differentially expressed (DE) non-coding RNAs and mRNAs potentially potentially involved in mediating liver immune responses and inflammation induced by T. gondii. During the acute stage of infection, several pro-inflammatory genes, including Lpin1, Usp2, Pim3, and Il6ra were significantly up-regulated in the liver. Among these, Lpin1 may be closely associated with the development of Enterobacteriaceae overgrowth. Conversely, some anti-inflammatory genes, such as Dmbt1, and Ddit4, were exclusively up-regulated during the chronic stage of infection. Gene ontology (GO) enrichment analysis further revealed the stage-specific features of liver functionality. Specifically, during the acute stage of infection, pathways associated with inflammation were significantly enriched. Interestingly, during the chronic stage of infection, pathways related to microbiota regulation, such as 'defense response to Gram-negative bacterium', 'antimicrobial humoral immune response mediated by antimicrobial peptide', and 'antimicrobial humoral response' were enriched. Additionally, competing endogenous RNAs (CeRNAs) networks revealed that numerous DElncRNAs and DEcircRNAs competitively regulated DEmiRNA mmu-miR-690, which targets the Nr1d1 gene. These findings provide insights into the complex interplay between the liver and gut microbiota during different stages of T. gondii infection.
      Conclusions: In summary, our results highlight the intricate interaction between the liver and gut microbiota in mice during T. gondii infection, with dynamic alterations observed in both the gut microbiota composition and the expression profiles of key genes in the liver over the course of the infection cycle.
      (© 2025. The Author(s).)
    • References:
      Am J Pathol. 2002 Oct;161(4):1187-98. (PMID: 12368192)
      PLoS One. 2010 Dec 30;5(12):e15224. (PMID: 21253009)
      Exp Ther Med. 2022 Sep 08;24(5):666. (PMID: 36168416)
      Nat Protoc. 2016 Sep;11(9):1650-67. (PMID: 27560171)
      G3 (Bethesda). 2023 Nov 1;13(11):. (PMID: 37717172)
      Ann Nutr Metab. 2012;61(2):160-74. (PMID: 23037511)
      Gut Microbes. 2020 Nov 1;11(6):1531-1546. (PMID: 32573321)
      Cell Res. 2020 Jun;30(6):492-506. (PMID: 32433595)
      Acta Trop. 2020 Mar;203:105301. (PMID: 31843385)
      Cell Host Microbe. 2013 Sep 11;14(3):318-28. (PMID: 24034617)
      Genome Biol. 2009;10(3):R25. (PMID: 19261174)
      Nutrients. 2019 Jul 25;11(8):. (PMID: 31349604)
      Nat Biotechnol. 2010 May;28(5):511-5. (PMID: 20436464)
      Clin Microbiol Infect. 2002 Oct;8(10):634-40. (PMID: 12390281)
      Front Physiol. 2021 May 26;12:688780. (PMID: 34122150)
      Nat Methods. 2016 Jul;13(7):581-3. (PMID: 27214047)
      Food Microbiol. 2015 Apr;46:494-500. (PMID: 25475320)
      J Biol Chem. 2002 Aug 30;277(35):32109-15. (PMID: 12050164)
      Front Cell Infect Microbiol. 2022 Jul 28;12:969832. (PMID: 35967867)
      Vet Clin North Am Small Anim Pract. 1987 Nov;17(6):1389-404. (PMID: 3328395)
      Nucleic Acids Res. 2012 Jan;40(1):37-52. (PMID: 21911355)
      Front Immunol. 2022 May 11;13:874021. (PMID: 35634334)
      J Immunol. 2010 Jun 15;184(12):7219-28. (PMID: 20483735)
      Biomedicines. 2020 Nov 16;8(11):. (PMID: 33207562)
      Parasitol Res. 2021 Jul;120(7):2303-2309. (PMID: 34110502)
      Gut Microbes. 2024 Jan-Dec;16(1):2391535. (PMID: 39182245)
      mBio. 2019 May 28;10(3):. (PMID: 31138751)
      Parasit Vectors. 2011 May 13;4:75. (PMID: 21569516)
      Ann Parasitol. 2021;67(2):137-149. (PMID: 34331850)
      Nat Biotechnol. 2020 Jun;38(6):685-688. (PMID: 32483366)
      Parasit Vectors. 2024 Jan 16;17(1):20. (PMID: 38229193)
      Genome Biol. 2010;11(2):R14. (PMID: 20132535)
      NPJ Biofilms Microbiomes. 2022 Nov 1;8(1):89. (PMID: 36319663)
      Exp Parasitol. 2017 Mar;174:25-30. (PMID: 28153801)
      Parasit Vectors. 2024 Jul 2;17(1):284. (PMID: 38956725)
      Int J Mol Sci. 2021 Jan 26;22(3):. (PMID: 33530560)
      J Hepatol. 2020 Mar;72(3):558-577. (PMID: 31622696)
      Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6. (PMID: 23193283)
      Gastroenterology. 2015 Jan;148(1):30-6. (PMID: 25447847)
      Gastroenterology. 2007 Nov;133(5):1499-509. (PMID: 17983803)
      Cancer Biol Med. 2023 Dec 23;21(2):. (PMID: 38148326)
      J Immunol. 2014 Nov 1;193(9):4614-22. (PMID: 25252959)
      Biomed Pharmacother. 2017 Oct;94:1176-1185. (PMID: 28830068)
      Rev Inst Med Trop Sao Paulo. 2010 Mar-Apr;52(2):107-10. (PMID: 20464132)
      Cell Insight. 2022 Jul 08;1(4):100047. (PMID: 37192862)
      Nat Rev Endocrinol. 2022 Feb;18(2):69. (PMID: 34848874)
      Nucleic Acids Res. 2013 Sep;41(17):e166. (PMID: 23892401)
      Microbiome. 2023 Dec 12;11(1):273. (PMID: 38087373)
      Scientifica (Cairo). 2018 Nov 1;2018:2308619. (PMID: 30515345)
      Poult Sci. 2022 Sep;101(9):102037. (PMID: 35901643)
      Brief Bioinform. 2018 Sep 28;19(5):803-810. (PMID: 28334140)
      Cell Mol Immunol. 2021 Jan;18(1):4-17. (PMID: 33318628)
      Sci Rep. 2022 Jan 24;12(1):1271. (PMID: 35075239)
      Cells. 2023 Jan 18;12(3):. (PMID: 36766701)
      Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Oct;1864(10):1328-1337. (PMID: 31220616)
      JCI Insight. 2018 Sep 20;3(18):. (PMID: 30232275)
      Nat Biotechnol. 2019 Aug;37(8):852-857. (PMID: 31341288)
      Mamm Genome. 2018 Aug;29(7-8):558-576. (PMID: 29785663)
      Parasit Vectors. 2016 Aug 03;9(1):427. (PMID: 27488578)
    • Contributed Indexing:
      Keywords: Toxoplasma gondii; CeRNA networks; Gut microbiota; Interaction; Liver; Non-coding RNAs; RNA sequencing
    • Accession Number:
      0 (RNA, Ribosomal, 16S)
      0 (MicroRNAs)
    • Publication Date:
      Date Created: 20250315 Date Completed: 20250513 Latest Revision: 20250513
    • Publication Date:
      20250514
    • Accession Number:
      PMC11908072
    • Accession Number:
      10.1186/s12866-025-03852-5
    • Accession Number:
      40087603